Company Number: 14958992

Analysis Date: 2025-07-29 13:22 UTC

Financial Health Assessment for METABOLIZM LTD

---

1. Financial Health Score: D

Explanation:
METABOLIZM LTD shows significant early-stage financial distress indicated by net liabilities, negative working capital, and negative shareholders’ funds within its first year of operation. While this is not uncommon for a newly incorporated company investing upfront, the current financial structure signals a weak financial position requiring close monitoring and corrective action.

---

2. Key Vital Signs

Vital Sign	Value	Interpretation
Cash at bank	£3,964	Limited cash reserve; a thin liquidity buffer.
Current Liabilities	£8,476	Short-term debts exceed cash and current assets.
Net Current Assets (Working Capital)	-£1,036	Negative working capital indicates liquidity strain.
Creditors > 1 year (Long-term liabilities)	£8,476	Long-term debt adds to financial obligations.
Net Assets	-£9,512	Company’s liabilities exceed assets (insolvency symptom).
Shareholders’ Funds	-£9,712	Negative equity, showing accumulated losses or undercapitalisation.
Number of Employees	1	Very small workforce, typical for start-ups.

What these vital signs indicate:

• Negative net assets and shareholders’ funds are the core "symptoms" of financial distress, suggesting the company is technically insolvent on a balance sheet basis.
• Negative working capital points to difficulty covering short-term obligations with current assets, raising liquidity concerns.
• Limited cash reserves mean the company has little financial "oxygen" to sustain operations without additional funding.
• The company is newly incorporated (2023-06-24), so early losses and negative equity can reflect initial investment costs rather than operational failure.

---

3. Diagnosis

METABOLIZM LTD is in its infancy and currently demonstrates signs akin to a patient in "financial shock" due to negative equity and working capital. The negative net assets and shareholder funds are the most telling "symptoms" of distress, implying the company’s liabilities outweigh its assets, which could limit its ability to raise further finance or trade with confidence.

At this stage, the company appears to be in a "critical phase" where early investments or start-up losses have yet to be offset by operational revenue. The absence of turnover figures limits understanding of revenue generation potential, but the negative net assets suggest the company has used funding or credit to finance its initial activities.

The directors’ statement notes the company qualifies for small company exemptions, and the filing is up to date, which is positive governance-wise.

---

4. Recommendations

Immediate Actions:

• Improve Cash Flow Management:
  The "healthy cash flow" is vital to keep the business breathing. Explore ways to increase cash inflows or negotiate better payment terms with creditors to ease liquidity pressure.

• Capital Injection:
  Consider an equity injection or shareholder loans to strengthen the balance sheet and convert negative equity into positive shareholders' funds.

• Cost Control:
  Keep overheads and expenses lean, given the limited financial resources and early losses.

• Revenue Generation Focus:
  Accelerate efforts to generate sustainable turnover and gross profit, especially important in manufacturing and pet food sectors where scale matters.

• Financial Forecasting & Monitoring:
  Implement robust budgeting and forecasting tools to anticipate cash needs and manage liabilities proactively.

• Professional Advice:
  Engage with financial advisors or insolvency practitioners early if cash flow issues worsen to avoid crisis scenarios.

---

Long-term Outlook (Prognosis):
If corrective financial measures are taken timely—improving liquidity, securing capital, and growing revenues—the company can transition from a fragile state to a more stable "financial health." Failure to address these "symptoms" may lead to insolvency or forced restructuring.

---